Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 10, 2018 FBO #5951
SOLICITATION NOTICE

66 -- CellEx System Procedural Kit

Notice Date
3/8/2018
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
 
ZIP Code
20892-5480
 
Solicitation Number
18-005237
 
Archive Date
3/23/2018
 
Point of Contact
Andre M. Moody, Phone: 3014022677
 
E-Mail Address
moodya@cc.nih.gov
(moodya@cc.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a notice of intent not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The Government intends to award a fixed price purchase order to Therakos, Inc. Raritan, NJ 08869. The Department of Transfusion (DTM) at the National Institutes of Health (NIH) Clinical Center (CC), Bethesda, MD has a requirement to procure the supply listed below: Quantity Description Catalog Number 23 CellEx System Procedural Kit CLXUSA The purpose of this acquisition is the purchase of THERAKOS CELLEX Photopheresis SYSTEM Procedural Kits CLXUSA, for extracorporeal photopheresis therapy to patients post stem-cell transplantation. Extracorporeal Photopheresis is a recognized therapy for graft-versus-host disease (GVHD) post stem cell transplantation, particularly the steroid-refractory patient population. By American Society for Bone Marrow Transplantation criteria, steroid-refractory GVHD patients estimated probability of death from complications of steroid refractory GVHD is 75%, complications would most-likely be infectious. This therapy, in conjunction with other GVHD modalities is a second-line therapy and appears to substantially improve the dismal prognosis of patients who require salvage therapy for GVHD. If this is not received, this could further endanger the health of our patients, causing an increased risk for post-stem-cell transplant complications, infection and death.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/18-005237 /listing.html)
 
Place of Performance
Address: 6707 Democracy Blvd., Suite 106, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN04848285-W 20180310/180308231811-940a166bdbb682df18ed4aad07a2d8a8 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.